The Medicines Company to Announce Third Quarter 2013 Financial Results on Wednesday, October 23, 2013

Conference Call to Be Held at 8:30 a.m. Eastern Time

(firmenpresse) - PARSIPPANY, NJ -- (Marketwired) -- 10/16/13 -- (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, October 23 at 8:30 a.m. Eastern Time to discuss third quarter 2013 financial results, operational developments, and outlook for 2013.

The conference call will be available via phone and webcast. The dial-in information is listed below:

Domestic Dial In: + 866 825.3209
International Dial In: + 617 213.8061
Passcode for both dial-in numbers: 71562508

Replay is available from 10:30 a.m. Eastern Time following the conference call through November 6, 2013. To hear a replay of the call dial 888 286.8010 (domestic) and 617 801.6888 (international). Passcode for both dial in numbers is 20051387.

This call is being webcast and can be accessed via The Medicines Company website at .

The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.





Contact:

Neera Dahiya Ravindran, MD
The Medicines Company
+1 (973) 290-6044


Michael Mitchell
The Medicines Company
+1 (973) 290-6097

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 16.10.2013 - 12:30 Uhr
Sprache: Deutsch
News-ID 306287
Anzahl Zeichen: 0

contact information:
Town:

PARSIPPANY, NJ

Kategorie:

Healthcare

Diese Pressemitteilung wurde bisher 236 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"The Medicines Company to Announce Third Quarter 2013 Financial Results on Wednesday, October 23, 2013"
steht unter der journalistisch-redaktionellen Verantwortung von

The Medicines Company (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

The Medicines Company to Participate in Upcoming Investor Conference Webcasts ...

PARSIPPANY, NJ -- (Marketwired) -- 11/27/13 -- The Medicines Company (NASDAQ: MDCO) is scheduled to present at the 25th Annual Piper Jaffray Healthcare Conference on December 4th at 12:30 PM Eastern Time. MDCO is also scheduled to present at the Opp ...

European Medicines Agency Accepts Marketing Authorization Application for The Me ...

PARSIPPANY, NJ -- (Marketwired) -- 11/21/13 -- The Medicines Company (NASDAQ: MDCO) today announced that the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for the investigational hemostatic agent ...

FDA Grants QIDP Designation to The Medicines Company's Investigational Anti ...

PARSIPPANY, NJ -- (Marketwired) -- 11/12/13 -- The Medicines Company (NASDAQ: MDCO) today announced that the U.S. Food and Drug Administration (FDA) has designated oritavancin as a Qualified Infectious Disease Product (QIDP). The QIDP designation pr ...

Alle Meldungen von The Medicines Company